Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Infusion Nursing"
DOI: 10.1097/nan.0000000000000283
Abstract: Blinatumomab has shown great potential for patients with chemotherapy-resistant B-cell acute lymphocytic leukemia. Blinatumomab's toxicity profile includes central nervous system toxicities, as well as cytokine release syndrome. Although neurological toxicities associated with blinatumomab are almost…
read more here.
Keywords:
administration;
administration challenges;
challenges associated;
addressing administration ... See more keywords